tirzepatide august 24 2025 A 3-year study of in participants with obesity and prediabetes showed substantial and sustained weight reduction and decreased risk of progression to diabetes with tirzepatide, as compared with placebo. Full SURMOUNT-1 Cardiometabolic Gains Backslide After Halting

However, women who are nursing an infant or breastfeeding must stay away from omeprazole

In men, obesity, diabetes and metabolic syndrome (a cluster of conditions that increase the risk of heart disease and stroke) have negative effects on fertility

Candidate Evaluation for Medical Weight Loss Those in Madisonville with a BMI of 30 or more, or 27 and above with conditions like hypertension, high cholesterol, or sleep apnea, may be ideal candidates for medical weight loss

The FDA currently has approved three forms of semaglutide: Ozempic , for treating type 2 diabetes Rybelsus , for the treatment of type 2 diabetes Wegovy , for chronic weight management Novo Nordisk manufactures all three forms of the drug

People who are pregnant or breastfeeding, who have active cancer, or who have certain medical conditions should generally avoid it unless a qualified clinician advises otherwise

FDA approval in 2021 (Wegovy , Novo Nordisk